The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti-LAG-3 antibody LBL-007 in combination with anti-PD-1 antibody tislelizumab with or without chemotherapy in patients with advanced nasopharyngeal cancer and other malignant tumors: A phase Ib/II dose escalation/expansion study.
 
Yunpeng Yang
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose
 
Song Qu
No Relationships to Disclose
 
Lei Liu
No Relationships to Disclose
 
Lisha Chen
No Relationships to Disclose
 
Kunyu Yang
No Relationships to Disclose
 
Xiaoming Huang
No Relationships to Disclose
 
Jingao Li
No Relationships to Disclose
 
Rensheng Wang
No Relationships to Disclose
 
Haisheng Zhu
No Relationships to Disclose
 
Shiwei Zhao
Employment - Leads Biolabs
 
Tao Li
Employment - Leads Biolabs
Leadership - Leads Biolabs
 
Shengli Cai
Employment - Leads Biolabs
Leadership - Leads Biolabs
 
Li Zhang
No Relationships to Disclose